PAVmed Newsroom

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Price Rule

PR NewswireDec 23 21:01

Express News | PAVmed Inc: Files for Mixed Shelf Offering of up to $125 Mln

BreakingsDec 21 06:17

Lucid Diagnostics Partners With VITALExam, To Enhance Access To Lucid's EsoGuard Esophageal DNA Test For Firefighters At Risk For Esophageal Precancer

BenzingaDec 19 21:17

Express News | Prospective Clinical Utility Study of Lucid Diagnostics' Esoguard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

BreakingsDec 11 21:01

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard Esophageal DNA Test Accepted for Peer-Reviewed Publication

PR NewswireDec 11 21:01

PAVmed Is Maintained at Buy by Ascendiant Capital

Dow JonesDec 9 17:35 · Ratings

PAVmed Analyst Ratings

BenzingaDec 9 17:22 · Ratings

Express News | PAVmed Inc : Ascendiant Capital Markets Cuts Target Price to $19 From $21

BreakingsDec 9 15:31

Express News | Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

BreakingsDec 3 21:01

Press Release: Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Dow JonesDec 3 21:01

PAVmed Shares Are Trading Higher After the Company Announced It and Lucid Diagnostics Submitted Complete Clinical Evidence for Its Esoguard Esophageal DNA Test.

BenzingaNov 20 21:38

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard Esophageal DNA Test

PR NewswireNov 20 20:56

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR NewswireNov 18 21:15

Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 16 20:32 · Ratings

PAVmed Positioned for Growth Despite Q3 Revenue Miss: Buy Rating Affirmed by Anthony Vendetti

TipRanksNov 16 20:15 · Ratings

Q3 2024 PAVmed Inc Earnings Call

Yahoo FinanceNov 15 19:23

PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 15 04:51 · Conference Call

10-Q: Q3 2024 Earnings Report

SECNov 15 00:39 · Announcements

Express News | PAVmed Inc: Qtrly Shr Loss $0.54

BreakingsNov 14 21:22

8-K: PAVmed Provides Business Update and Third Quarter 2024 Financial Results

SECNov 14 21:21